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Bacterial signal transductionCyclic-di-AMP (c-di-AMP) is a bacterial secondary messenger involved in various processes, includ-
ing sensing of DNA-integrity, cell wall metabolism and potassium transport. A number of c-di-AMP
receptor proteins have recently been identiﬁed in Staphylococcus aureus. One of them - PstA -
possesses a ferredoxin-like fold and is structurally related to the class of PII signal-transduction
proteins. PII proteins are involved in a large number of pathways, most of them associated with
nitrogenmetabolism. In this study we describe themode of c-di-AMP binding and subsequent struc-
tural changes of S. aureus PstA. An altered architecture in PstA compared to canonical PII proteins
results in differences in ligand coordination.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Nucleotide secondary messengers are key components of the
signal transduction networks that link sensory input signals to
the responses of the cell. The most prominent examples in bacteria
are cyclic AMP and (p)ppGpp, both of which control genome wide
expression. The cyclic di-nucleotide messenger molecule c-di-GMP
acts as a ‘‘lifestyle’’ signal, regulating bioﬁlm formation, cell cycle
progression, development and virulence. In the past few years
two new members of bacterial nucleotide messengers have been
identiﬁed, namely c-di-AMP and 3,3-cGAMP. The latter is little
characterized but it has been shown to play a role in Vibrio cholerae
gastrointestinal colonization [1] and is related to the 2,3-cGAMP
synthesized by the eukaryotic innate immune DNA sensor cGAS
[2,3]. The identiﬁcation of c-di-AMP in 2008 [4] started a struggle
for the identiﬁcation of c-di-AMP related signaling pathways [5]
and we are still at the beginning of understanding how c-di-AMP
signaling is initiated, how the signal is transduced and which cel-
lular processes are ﬁnally regulated. After the initial discovery of
c-di-AMP in the crystal structure of Thermotoga maritima DisA
[4], more diadenylate cyclase (DAC) domain proteins have been
identiﬁed in a variety of bacteria [6–10]. Different functions were
assigned to c-di-AMP signaling and it has been shown that deletionof all DAC domain proteins is lethal in Bacillus subtilis [9]. On the
one hand, DNA damage or subsequent post-repair/recombination
states of the DNA result in a reduced level of c-di-AMP due to inhi-
bition of DisA, leading to sporulation delay in B. subtilis [11]. On the
other hand, c-di-AMP has been reported to be involved in cell wall
homeostasis [12], fatty acid synthesis [13] and potassium transport
[14]. Aside from the DAC domain synthesizing c-di-AMP [4,15],
there is little structural information about c-di-AMP degradation
by the phosphodiesterase GdpP [16,17] or c-di-AMP-binding
receptors. To date, six c-di-AMP receptors have been identiﬁed:
the transcription factor DarR from Mycobacterium smegmatis [13];
ydaO riboswitches [18–20]; the potassium transport associated
proteins KtrA and KdpD; the PII-like protein PstA from the patho-
gen Staphylococcus aureus [14]; and the well-characterized protein
pyruvate carboxylase, which was unexpectedly shown in a recent
structural and biochemical study to be allosterically regulated by
c-di-AMP [21].
The fact that c-di-AMP binds to PstA implies that the cyclic
dinucleotide might also be involved in regulation of metabolism.
PstA shares a ferredoxin-like fold with proteins of the PII signal
transduction family, which are omnipresent in bacteria, archaea
and plants, and probably belong to the most widespread signal
transducing proteins in nature. PII proteins are mainly involved
in the regulation of central metabolic processes and in particular
cellular nitrogen metabolism (e.g. reviewed in [22]). After sensing
of a ligand such as 2-oxoglutarate (2-OG) and/or adenosine nucle-
otides, PII proteins regulate target proteins via protein–protein
interactions with transcription factors, membrane transporters
46 M. Müller et al. / FEBS Letters 589 (2015) 45–51and different enzymes. All PII proteins are trimers and consist of
three identical subunits with an approximate molecular weight
of 12–13kDa each. PII proteins have a compact core domain with
a double bab-architecture (ferredoxin-like fold) and inter-subunit
clefts for ligand binding. Additional structural features are one
large protruding loop (T-loop), a smaller B-loop and a C-terminal
loop (C-loop). Whereas the latter are involved in ligand binding,
the T-loop is ﬂexible and rarely visible in crystal structures.
However, the intrinsic ﬂexibility is probably needed for regulatory
protein–protein interactions. In bacteria, the T-loop is often post-
translationally modiﬁed through uridylation of Tyr51 with effects
on the signal transduction. All three ligand binding sites can bind
one nucleotide and one 2-OG molecule each. While ATP binding
is cooperative with 2-OG, ATP and ADP bind competitively and
ADP acts antagonistic to 2-OG. The crystal structure of Azospirillum
brasilense GlnZ in complex with ATP, 2-OG and a Mg2+ ion [23] was
the ﬁrst complex structure to shed light on the mode of ligand
binding. Both ATP and 2-OG are bound in the inter-subunit cleft
and, together with conserved residues in the binding cleft, coordi-
nate the Mg2+ ion.
We solved the crystal structures of S. aureus PstA with and with-
out its ligand c-di-AMP and were thus able to analyze the coordi-
nation of c-di-AMP and subsequent structural changes in PstA.
The overall architecture of PstA differs from PII proteins with
respect to the protruding loops that are involved in interactions
with both ligands and targets. In agreement with other structures
of PII proteins, c-di-AMP is bound in the inter-subunit clefts. In con-
trast, however, these clefts are closed by the small T-loops bending
upwards and not the C-loops as previously observed.2. Materials and methods
2.1. Cloning, expression and protein puriﬁcation
S. aureus PstA (SACOL0525) was cloned into the pET28a expres-
sion vector via NdeI and NotI restriction sites. His6-tagged PstA was
expressed in E. coli Rosetta BL21(DE3) cells grown in LB. After
reaching an OD600 of 0.6, expression was induced by addition of
0.2 mM IPTG and the temperature was lowered to 18 C. Cells were
harvested after 18 h and lysed in buffer A (50 mM Tris–HCl,
300 mM NaCl, 10 mM Imidazole, 10% v/v Glycerol, pH 7.5) via son-
ication. The cell lysate was cleared by centrifugation and loaded
onto a Ni–NTA column (Qiagen). After washing with buffer A and
buffer B (50 mM Tris–HCl, 300 mM NaCl, 40 mM Imidazole, 10%
v/v Glycerol, pH 7.5) the protein was eluted with buffer C
(50 mM Tris–HCl, 300 mM NaCl, 250 mM Imidazole, 5% v/v Glyc-
erol, pH 7.5). PstA was dialyzed against buffer D (50 mM Tris–
HCl, 100 mM NaCl, 5% v/v Glycerol, pH 7.5) and loaded onto a
HiTrap Q HP (GE Healthcare). A linear gradient to 100% buffer E
(50 mM Tris–HCl, 1 M NaCl, 5% v/v Glycerol, pH 7.5) was used to
elute the protein. PstA-containing fractions were pooled, concen-
trated and loaded onto a HiLoad Superdex 75 column (GE Health-
care) equilibrated with running buffer F (20 mM Tris–HCl, 150 mM
NaCl, 5% v/v Glycerol, pH 7.5). The PstA peak fractions were con-
centrated to 6 mg/ml and ﬂash-frozen in liquid nitrogen for later
use.
2.2. Crystallization, data collection and structure reﬁnement
S. aureus PstA crystals were grown by hanging drop vapor-diffu-
sion at 20 C. Crystals were obtained by mixing 2 lL of protein
(6 mg/ml) and 1 lL reservoir solution (55% v/v MPD, 0.1 M sodium
acetate pH 4.3, 10 mM calcium chloride) with a total reservoir
volume of 300 lL in the well. For co-crystallization of PstA with
c-di-AMP, 1 lL of protein (6 mg/ml) supplemented with 0.75 mMc-di-AMP was mixed with 1 lL of reservoir solution (6% w/v PEG
8000, 0.1 M HEPES/NaOH pH 7.0, 0.2 M calcium acetate) with a res-
ervoir volume of 300 lL. Crystals were ﬂash-cooled in liquid nitro-
gen either directly from their mother liquor or after transfer into
mother liquor supplemented with 25% v/v PEG 400 as a cryo-pro-
tectant (for crystals with c-di-AMP). Diffraction data were col-
lected at the Swiss Light Source (Paul-Scherrer institute, Villigen,
Switzerland) at the beamline X06SA at 100 K. Diffraction data were
indexed and scaled using XDS/XSCALE [24]. The structure was
determined by molecular replacement using PHASER [25] within
the CCP4 package [26] using Pediococcus pentosaceus PII-like pro-
tein (PDB code 3m05) as search model. Structure reﬁnement com-
prised cycles of manual model building/reﬁnement steps with Coot
[27] and automatic reﬁnement using PHENIX [28]. The data collec-
tion and reﬁnement statistics are shown in Table 1. Coordinates
and structure factors have been deposited in the Protein Data
Bank as 4wk1 and 4wk3. All ﬁgures were prepared using PyMOL
[29].
2.3. Size-exclusion coupled right-angle laser light scattering (SEC-
RALS)
SEC-RALS data were collected using a Malvern/Viscotek system
(TD270 RALS- and VE3580 RI-detector) connected to an ÄKTAmicro
system equipped with a Superdex 200 Increase (10/300) column
(GE Healthcare). To calibrate the system BSA (66kDa) was used.
Data were evaluated with the OmniSEC software supplied with
the instrument.2.4. Surface plasmon resonance experiments
Surface plasmon resonance experiments to analyze binding of
c-di-AMP to S. aureus PstA were performed using a Biacore
X100+ system (GE Healthcare). S. aureus PstA was coupled to a
CM-5 chip via amine coupling chemistry and free activated groups
were inactivated using ethanolamine. To increase the sensitivity of
the nucleotide binding we saturated the chip surface with PstA
(5800 RU). Kinetic data were recorded for injections of c-di-AMP
(and other nucleotides) in HBS-EP buffer (150 mM NaCl, 10 mM
HEPES/NaOH pH 7.4, 3 mM EDTA, 0.05% P-20). Data from an empty
ﬂow cell (FC1) were subtracted as reference to correct for unspe-
ciﬁc binding of the analytes to the chip surface. Data were analyzed
using the Biacore X100 Evaluation software.2.5. Thermal shift assays
Thermal stability of PstA in presence of ligands was probed
using ﬂuorescence thermal shift assays [30]. 19 lM PstA (+1 mM
ligand) in 50 mM Tris–HCl pH 7.5, 150 mM NaCl, 5% v/v glycerol,
5 mM MgCl2 with SYPRO orange (ﬁnal concentration 4x, Invitro-
gen) was analyzed in a real-time PCR machine. After equilibration
at 5 C for 30 s the melting curve was measured using a gradient
with 0.5 K/30 s from 5 C to 100 C and one scan/0.5 K.2.6. Differential radial capillary action of ligand assay
DRaCALA assays were performed as e.g. described in [14].
20 lM S. aureus PstA or the control ATP-binding protein (human
nucleotidyl transferase) in assay buffer (50 mM Tris–HCl pH 7.5,
150 mM NaCl, 5 mM MgCl2) were incubated for 5 min with differ-
ent concentrations of ATP-a32P (1–10 nM). 3.5 lL of the reaction
mixture were spotted on a nitrocellulose membrane, dried and
radioactivity was detected using a phosphor-imaging system (GE
Healthcare).
Table 1
Crystal parameters, data collection and reﬁnement statistics for S. aureus PstA.
Crystal data PstA PstA + c-di-AMP
Space group P4332 H32
Molecules per ASU 1 1
Unit cell parameters
a, b, c (Å) 99.32, 99.32, 99.32 68.1, 68.1, 135.74
a, b, c () 90, 90, 90 90, 90, 120
Data collection statistics
Diffraction source SLS beamline X06SA SLS beamline X06SA
Wavelength (Å) 0.99998 0.99998
Data processing statistics
Resolution range (Å) 70.23–2.60 (2.67–2.60) 50–1.98 (2.03–1.98)
No. of observed reﬂections 701580 (14290) 141089 (2745)
No. of unique reﬂections 5565 (392) 8523 (512)
Completeness (%) 99.9 (99.2) 97.7 (81.4)
Multiplicity 36.2 (36.1) 16.6 (5.4)
I/rI 33.1 (2.5) 23.6 (2.0)
Rmeas (%) 7.0 (198) 7.4 (105.3)
Reﬁnement
Resolution (Å) 44.42–2.60 44.52–1.98
No. of used reﬂections 5563 8522
Rwork (%)/Rfreea (%) 25.2/29.2 18.8/22.9
No. of atoms (total) 598 779
Protein 593 (77 residues) 703 (92 residues)
Ligand 1 1 (Ca2+); 43 (c-di-AMP)
Water 4 23
Average B factors (Å2)
Wilson B factor 85.36 42.75
Overall 98.12 54.3
Protein 98.11 54.3
Ligands/water Cl 129.5/89.6 c-di-AMP 49.1; Ca2+ 70.7/54.2
R.M.S. deviations
Bond lengths (Å)/angles () 0.009/1.18 0.008/1.20
Ramachandran plot analysis
Favoured (%) 98.6 98.9
Allowed (%) 1.4 1.1
Disallowed (%) 0 0
PDB identiﬁer 4wk3 4wk1
Values in parentheses are for the highest resolution shell.
a 10% of the total number of reﬂections were used for the Rfree calculations.
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The S. aureus protein PstA has a ferredoxin-like fold and its core
domain shares the highly conserved architecture of the GlnB/K PII
proteins to which it is structurally closely related. A comparison
of the secondary structure of PstA with canonical PII proteins
(e.g. E. coli GlnK), however, clearly shows that the lengths of the
loops are exchanged (Fig. 1A). The loop connecting the double
bab-motif comprises only 8 amino acids and is thus substantially
shorter than the approximately 20 residue long T-loop typically
present in this domain. Vice versa, the 33 residue long B-loop in
the vicinity of the ligand binding cleft is signiﬁcantly larger in S.
aureus PstA than the eight residue loop in GlnK. The carboxy-termi-
nal C-loop that usually covers the ligand binding cleft is absent in S.
aureus PstA. As the overall properties of PstA deviate from previ-
ously described PII proteins, we ﬁrst analyzed the biochemical
properties of PstA in solution to exclude the possibility that the
protein forms different oligomers to the canonical trimeric PII pro-
teins. We thus performed size-exclusion chromatography coupled
right-angle light scattering (SEC-RALS) experiments to determine
the molecular weight in solution (Fig. 1B and C). Both the SEC-RALS
data and the molecular weight determined from the hydrodynamic
radius in size-exclusion chromatography show that PstA is a
monodisperse trimeric species in solution (Mwtheoretical (trimer) =
42kDa, MwSEC-RALS = 43kDa, MwSEC = 47kDa). The fact that the
apparent molecular weight from size-exclusion chromatography
is higher than the molecular weight determined by light scatteringis probably due to the protruding loops in PstA. Flexible regions
lead to an increase in hydrodynamic radius and thus to a larger
retention volume than a globular protein of the same size.
3.1. Binding of c-di-AMP
To probe binding of small molecules we measured the thermal
stability of PstA in absence and presence of putative regulatory
ligands using ﬂuorescence-based thermal shift assays (TSA). In
good agreement with PII proteins [31], PstA shows a remarkably
high thermal stability with an approximate melting temperature
of 74.5 C under the conditions used. Since ligand binding usually
increases the melting temperature of a protein, we analyzed the
melting behavior of PstA in the presence of nucleotides and/or 2-
oxoglutarate (2-OG, a-ketoglutaric acid). While guanosine and
non-cyclic adenosine nucleotides do not alter the melting temper-
ature, c-di-AMP shifts the melting temperature of PstA by approx-
imately 19 C to 93.5 C, indicating a remarkable gain in stability
caused by a higher number of interactions within the complex.
These observations are in good agreement with experiments by
Corrigan et al. [14] that showed binding of c-di-AMP, but not other
nucleotides, in differential radial capillary action of ligand assays
(DRaCALA). The addition of 1 mM 2-OG had no detectable effect
on the melting behavior of PstA.
In order to quantify the afﬁnity and kinetic properties of c-di-
AMP binding to PstA, we performed surface plasmon resonance
(SPR) experiments. Amino-reactive coupling chemistry was used
Fig. 1. Biochemical analysis of S. aureus PstA. (A) Comparison of the secondary structure of S. aureus PstA with a member of the canonical PII protein family (E. coli GlnK). The
lengths of the T- and B-loops are swapped in PstA compared to GlnK. (B) Size-exclusion chromatogram of a PstA sample (red curve) loaded onto a Superdex 200 Increase
column and a molecular weight standard shown in black (peaks labeled with the respective masses of the proteins in kDa). MwSEC(PstA) = 47kDa was calculated using a
calibration curve generated from the Mw-standard. (C) SEC-RALS curve of a PstA peak on the same column as in B. The molecular weight determined by RALS is constant for
the entire PstA peak, indicating a monodisperse sample with a molecular weight of MwSEC-RALS = 43kDa (Mwtheoretical (trimer) = 42kDa). (D) Surface plasmon resonance (SPR)
experiments. Injections of different concentrations of c-di-AMP (colored curves) over the immobilized S. aureus PstA chip-surface (FC2-1). The black curves show the ﬁt of
kinetic analysis with ka = 6.4  105 M1 s1, kd = 0.007 s1, RUmax = 173 for the binding of one c-di-AMPmolecule to each PstA monomer. (E) Injections of different nucleotides
show that ADP, AMP and c-di-GMP do not bind to PstA. ATP only binds to a small extent and this could not be conﬁrmed in a DRaCALA assay. ATP binding is only observed in
the positive control.
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concentrations of c-di-AMP (31.25–250 nM) in HBS-EP buffer were
injected as the analyte (Fig. 1D). PstA displays robust binding of the
cyclic di-nucleotide with KD = 109 nM, an association rate of
ka = 6.4  105 M1 s1 and a slow dissociation rate of kd = 0.07 s1.
We also performed injections with ATP/Mg2+, ADP, AMP, c-di-GMP
and 2-OG (Fig. 1E). Only the ATP sample showed binding to PstA,
albeit with much lower afﬁnity, and no binding of AMP, ADP,
c-di-GMP and 2-OG was detected under the conditions used. A com-
bination of c-di-AMP and 2-OG resulted in comparable binding
kinetics and KD to c-di-AMP alone. The high afﬁnity for c-di-AMP
is mainly determined by the relatively fast on-rate and the slow
dissociation kinetics. In comparison, the steep RU increase in
ATP-binding sensorgrams indicates that both ATP binding and dis-
sociation are much faster (beyond the sampling rate of the SPR
instrument and thus kaP 107 M1 s1), indicating that ATP-bind-
ing is energetically less favorable. A DRaCALA assay, however, did
not show any binding of radioactively labeled ATP to PstA. Both
the very fast on- and off-rates and weak binding observed in the
SPR experiment indicate a transient interaction, which we deem
unlikely to be of biological signiﬁcance.3.2. Crystal structures of PstA in absence and presence of c-di-AMP
To analyze the molecular details of c-di-AMP binding, we crys-
tallized S. aureus PstA in the presence and absence of the cyclic
dinucleotide. Apo PstA and c-di-AMP-PstA crystallized in the space
groups P4332 and H32, respectively, with one molecule per asym-
metric unit. Both structures were solved by molecular replacement
using the structure of P. pentosaceus PEPE_1480 (PDB code 3m05)
as a search model, which we identiﬁed through homology searches
using HHpred [32]. Traceable electron density covered 8 residues
from the N-terminal puriﬁcation tag and PstA residues 1–66 and
92–109 (numbers given for the complex structure). These residues
mainly comprise the double bab-motif while the loop regions
lacked traceable electron density and are thus likely to be ﬂexible
in the crystals (Fig. 2A). Statistics of data collection and model
reﬁnement are shown in Table 1. As suggested by the secondary
structure comparison (Fig. 1A), the structure of PstA shows no
obvious changes to the double bab-motif of the ferredoxin-like fold
but the T- and B-loops are swapped in length with respect to
canonical PII proteins. Beta strands b1–b4 form the core of the PstA
trimer while a-helices a1 and a2 are on the outside (Fig. 2A and B).
Fig. 2. Crystal structure of S. aureus PstA. (A) PstA monomer as present in the asymmetric unit. Residues in the B-loop region could not be traced in the electron density. The
strand b5 extends the b-core domain of the neighboring PstA molecule by interacting with b4. (B) PstA trimer (approximate height 25 Å and diameter 40 Å) with bound c-di-
AMP in side (upper part) and bottom views (lower part). The c-di-AMP moieties are deeply buried in the inter-subunit clefts. (C) Superposition of PstA and PII proteins. The
ﬁgure illustrates the structural similarity between S. aureus PstA (blue), A. brasilense GlnZ (PDB code 3mhy, grey, RMSD 1.18 Å) and E. coli GlnK (PDB code 2gnk, green, RMSD
0.854 Å).
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unit, where it interacts with b4 and thus stabilizes the trimer. The
superposition of S. aureus PstA, E. coli GlnK and also A. brasilense
GlnZ (Fig. 2C) reveals the high overall structural conservation of
the ferredoxin-like core domains.
In the complex structure of PstA with c-di-AMP all three inter-
subunit binding clefts are occupied by the cyclic dinucleotide.
The c-di-AMP moiety is almost completely buried in the binding
cleft and is stabilized by a set of hydrophobic and ionic interac-
tions. The binding cleft is clearly positively charged and almost
perfectly matches the shape of the adenosine dinucleotide
(Fig. 3A – electrostatic surface). Fig. 3B shows the c-di-AMP mol-
ecule with its respective electron density. The buried ‘‘inner’’ half
of c-di-AMP is almost completely protected from the solvent area
and coordinated by Asn-41, which forms a hydrogen bond with
the 20-hydroxyl group of the ribose, and additionally stabilized
via a backbone interaction with Gly-47, which interacts with N6
of adenine and thereby distinguishes between adenine and guan-
ine cyclic dinucleotides. In comparison to the nucleotide free
state, the small T-loop (residues 34–38), which is disordered in
the apo state, becomes stabilized in the complex state and bends
up towards the second ‘‘outer’’ adenine moiety. The base stacks
with residues Phe-36 and Arg-26 and contributes to the extre-
mely good coordination. This shielding and excessive ligand sta-
bilization is in good agreement with the high binding afﬁnity
observed by surface plasmon resonance and the melting temper-
ature shift in TSA. Interestingly, c-di-AMP shows a slower associ-
ation rate than ATP, most probably due to the slower migration
into the binding cleft that is just large enough to accommodate
this molecule. To date, only one other protein complex with
bound c-di-AMP has been reported, which is structurally verydifferent [21] and we have not identiﬁed a common recognition
motif for c-di-AMP.
3.3. Structural changes upon c-di-AMP binding and signal
transduction
The overall structural changes between apo and complex states
visible in the crystal structures are mainly short range movements
in the core domain and the stabilization of the short T-loop (Fig. 3C
and D). These structural changes upon ligand binding are sup-
ported by the fact that soaking of apo PstA crystals did not produce
any diffracting crystals, possibly due to conformational changes
disturbing the crystal lattice during binding of c-di-AMP. The high
similarity of the apo and complex structures is reﬂected in a very
low RMSDoverall = 0.451 Å and also in the low per-residue RMSDs
of the core domains (Fig. 3D). Because of the large amount of ﬂex-
ibility in the loop regions it is not possible to judge if any additional
conformational changes in the B-loop occur in vivo. The loop
regions have been shown to be crucial for signal transduction in
all PII proteins [22] but it is possible that PstA may function differ-
ently. Since we have no information on the structural changes of
the B-loop due to lack of electron density, we can only speculate
how PstA transduces signals, one option being that the longer
B-loop instead of the T-loop mediates downstream signaling.
Fig. 3E shows a superposition of the structures of the PII protein
GlnZ from A. brasilense in complex with ATP/2-OG (PDB code
3mhy) and PstA in complex with c-di-AMP. The overall shape
and surface properties are highly similar and the ATP and
c-di-AMP binding clefts superpose closely. The ‘‘inner’’ base of
c-di-AMP is almost in the same position as the ATP molecule in
GlnZ. Interestingly, a second positively charged cavity in the direct
Fig. 3. Ligand binding. (A) PstA in solvent accessible electrostatic surface representation with c-di-AMP bound (blue = 5kT/e to red = 5kT/e). (B) Coordinated c-di-AMP
molecule in the inter-subunit cleft with the corresponding electron density at 1r (simulated annealing composite omit map). The ‘‘outer’’ adenine moiety is stacked by R26
and F36 while the ‘‘inner’’ adenine is speciﬁcally recognized at N6 through a backbone interaction with G47. (C) Superposition of apo state PstA (shown in beige) and its c-di-
AMP complex (shown in blue, RMSD 0.451 Å). Although no major structural changes in the overall architecture can be observed upon ligand binding, the T-loop becomes
ordered and stabilizes the c-di-AMP moiety. (D) The plot shows the B-factors for the main chains of apo PstA (grey) and PstA-c-di-AMP complex (black) as well as the RMSD
values for the Ca-atoms (blue curve, right axis) in the superposition of both structures (c.f. C). The T-Loop (residues 30–40) is clearly stabilized in the c-di-AMP complex.
Additionally, the adjacent helix (residues 10–20) binds to the T-loop and thus has lower B-factors in the complex structure than in the apo structure. (E) Superposition of the
PstA-c-di-AMP complex (blue) with GlnZ in complex with ATP/Mg2+/2-OG (PDB code 3mhy, shown in grey, RMSD 1.18 Å). The ‘‘inner’’ adenine of c-di-AMP and ATP bound by
GlnZ superimpose almost perfectly.
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static surface representation (Fig. 3A), which is sufﬁciently large
to accommodate an additional small molecule ligand. As several
structures of PII proteins contain 2-OG close to ATP [23] bridged
by a Mg2+ ion, this cavity might also be a binding site for a nega-
tively-charged ligand. Even though our thermal shift assays and
SPR experiments do not indicate binding of 2-OG by PstA under
the conditions used, we cannot exclude the possibility that this
ligand (or another small molecule) might bind in addition to
c-di-AMP. From the structural point of view the second cavity
would certainly allow accommodation of a ligand but its function
remains to be analyzed in further studies.
We were able to structurally analyze c-di-AMP sensing by a sig-
nal transducing protein for the ﬁrst time. Even though PstA shares
its overall structural elements with canonical PII proteins, signiﬁ-
cant differences, such as the swapped lengths of the B- and T-loops
and the missing C-loop, result in altered ligand binding properties.
Future research will show which target proteins are affected by
PstA and the mechanism through which this occurs. This study
substantially broadens our understanding of how c-di-AMP is rec-
ognized by target proteins.
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